Phase 2 trial of temozolomide and pegylated liposomal doxorubicin in the treatment of patients with glioblastoma multiforme following concurrent radiotherapy and chemotherapy

Journal of Clinical Neuroscience

Volumn 18, Issue 11, 2011, Pages 1444-1448

  Ananda, Sumitra ^a   Nowak, Anna K ^b,f   Cher, Lawrence ^c   Dowling, Anthony ^d   Brown, Chris ^e   Simes, John ^e   Rosenthal, Mark A ^a,e  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c AUSTIN HEALTH   (Australia)

^d ST VINCENT S HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Glioblastoma; Pegylated liposomal doxorubicin; Temozolomide

Indexed keywords

DOXORUBICIN; TEMOZOLOMIDE;

ADULT; AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLIOBLASTOMA; HAND FOOT SYNDROME; HUMAN; MALE; MUCOSA INFLAMMATION; MULTIPLE CYCLE TREATMENT; NAUSEA AND VOMITING; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT RESPONSE;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; DACARBAZINE; DISEASE-FREE SURVIVAL; DOXORUBICIN; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 80053565518     PISSN: 09675868     EISSN: 15322653     Source Type: Journal    
DOI: 10.1016/j.jocn.2011.02.026     Document Type: Article

References (26)

1. D.N. Louis, H. Ohgaki, and O.D. Wiestler The 2007 WHO classification of tumors of the central nervous system 2007 IARC Press Lyon, France
2. Central Brain Tumor Registry of the United States, 2000-2004. CBTRUS 2008 statistical report: primary brain tumors in the United States, 1998-2002; 2008. < http://www.cbtrus.org/reports/2007-2008/2007report.pdf > [accessed 07.07.2008].
3. A. Jemal, A. Thomas, and T. Murray Cancer statistics, 2002 CA Cancer J Clin 52 2002 23 47 (Pubitemid 34110469)
4. R. Stupp, W.P. Mason, and M.J. van den Bent Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N Engl J Med 352 2005 987 996 (Pubitemid 40349501)
5. R. Stupp, M.E. Hegi, and W.P. Mason Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial Lancet Oncol 10 2009 459 466
6. A. Gabizon, R. Catane, and B. Uziely Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes Cancer Res 54 1994 987 992 (Pubitemid 24085451)
7. B. Uziely, S. Jeffers, and R. Isacson Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies J Clin Oncol 13 1995 1777 1785
8. T. Siegal, A. Horowitz, and A. Gabizon Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy J Neurosurg 83 1995 1029 1037 (Pubitemid 26048143)
9. P. Hau, K. Fabel, and U. Baumgart Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma Cancer 100 2004 1199 1207 (Pubitemid 38325948)
10. U.S. Sharma, A. Sharma, and R.I. Chau Liposome-mediated therapy of intracranial brain tumors in a rat model Pharm Res 14 1997 992 998 (Pubitemid 27371396)
11. M. Volm, R. Oratz, and A. Pavlick A phase I study of liposomal doxorubicin, temozolomide in patients with advanced cancer Proc Am Soc Clin Oncol 19 2000 [abstract]
12. S.L. Chua, M.A. Rosenthal, and S.S. Wong Phase 2 study of temozolomide and Caelyx in patients with recurrent glioblastoma multiforme Neuro-oncol 6 2004 38 43 (Pubitemid 38139638)
13. D.R. Macdonald, T.L. Cascino, and S.C. Schold Jr. Response criteria for phase II studies of supratentorial malignant glioma J Clin Oncol 8 1990 1277 1280 (Pubitemid 20195640)
14. R. Simon Optimal two-stage designs for phase II clinical trials Control Clin Trials 10 1989 1 10 (Pubitemid 19099520)
15. H.A. Fine, K.B. Dear, and J.S. Loeffler Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults Cancer 71 1993 2585 2597 (Pubitemid 23100496)
16. L.A. Stewart Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials Lancet 359 2002 1011 1018 (Pubitemid 34286538)
17. M.D. Walker, E. Alexander Jr., and W.E. Hunt Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial J Neurosurg 49 1978 333 343 (Pubitemid 9013313)
18. Medical Research Council Brain Tumor Working Party. Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol 2001;19:509-18.
19. K. Clarke, R.L. Basser, and C. Underhill KRN8602 (MX2-hydrochloride): an active new agent for the treatment of recurrent high-grade glioma J Clin Oncol 17 1999 2579 2584 (Pubitemid 29368261)
20. K. Fabel, J. Dietrich, and P. Hau Long-term stabilization in patients with malignant glioma after treatment with liposomal doxorubicin Cancer 92 2001 1936 1942 (Pubitemid 32952514)
21. M. Brada, K. Hoang-Xuan, and R. Rampling Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse Ann Oncol 12 2001 259 266 (Pubitemid 32223879)
22. M.T. Harris, M.A. Rosenthal, and D.L. Ashley An Australian experience with temozolomide for the treatment of recurrent high grade gliomas J Clin Neurosci 8 2001 325 327 (Pubitemid 32666690)
23. R. Stupp, M. Gander, and S. Leyvraz Current and future developments in the use of temozolomide for the treatment of brain tumours Lancet Oncol 2 2001 552 560 (Pubitemid 33586868)
24. W.K. Yung, M.D. Prados, and R. Yaya-Tur Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse. Temodal Brain Tumor Group J Clin Oncol 17 1999 2762 2771 (Pubitemid 29415233)
25. K.R. Lamborn, W.K. Yung, and S.M. Chang Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas Neuro-oncol 10 2008 162 170
26. P.Y. Wen, D.R. Macdonald, and D.A. Reardon Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group J Clin Oncol 28 2010 1963 1972